Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New blood test spots silent liver metastases before pancreatic cancer surgery

NCT ID NCT07224802

First seen Nov 05, 2025 · Last updated May 01, 2026 · Updated 24 times

Summary

This study looked at whether a blood test that measures tiny particles called exosomes can find early liver metastasis in people with pancreatic cancer before they have surgery. The test checks for specific genetic material in the blood to identify patients at high risk of hidden liver spread. If successful, this approach could help doctors choose the best treatment plan for each patient, potentially avoiding unnecessary surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PDAC - PANCREATIC DUCTAL ADENOCARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • City of Hope Medical Center

    Duarte, California, 91016, United States

Conditions

Explore the condition pages connected to this study.